Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB

Journal of Neuroscience Research

Volumn 79, Issue 3, 2005, Pages 318-328

  Dang, Ian ^a,b   DeVries, George H ^a,c,d  

^a VA Hospital   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d HINES VA HOSPITAL   (United States)

Author keywords

Akt; Calcium; Calmodulin kinase II (CAMKII); Neurofibromatosis type 1; Schwann cells

Indexed keywords

CALCIUM ION; CALMODULIN KINASE 2 INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; NEUROFIBROMIN; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE B; THAPSIGARGIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CALCIUM SIGNALING; CELL GROWTH; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CALCIUM SIGNALING; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NERVE SHEATH NEOPLASMS; NEUROFIBROMATOSIS 1; NEUROFIBROMIN 1; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SCHWANN CELLS;

EID: 14044275085     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20334     Document Type: Article

References (42)

1. Ansselin AD, Davey DF, Allen DG. 1994. ATP evokes a rise in intracellular calcium in cultured rat Schwann cells. Int J Neurosci 74:148.
2. Badache A, DeVries GH. 1998. Neurofibrosarcoma-derived Schwann cells overexpress platelet-derived growth factor (PDGF) receptors and are induced to proliferate by PDGF-BB. J Cell Physiol 177:334-342.
3. Badache A, Muja N, DeVries GH. 1998. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis. Oncogene 17:795-800.
4. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J. 1992. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356:713-715.
5. Birindelli S, Perrone F, Oggionni M, Lavarino C, Pasini B, Vergani B, Ranzani GN, Pierotti MA, Pilotti S. 2001. Rb and TP53 pathway-alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. Lab Invest 81:833-844.
6. Casella GT, Wieser R, Bunge RP, Margitich IS, Katz J, Oison L, Wood PM. 2000. Density dependent regulation of human Schwann cell proliferation. Glia 30:165-177.
7. Cichowski K, Shih TS, Schmitt E, Santiago S, Reilly K, McLaughlin ME, Bronson RT, Jacks T. 1999. Mouse models of tumor development in neurofibromatosis type 1. Science 286:2172-2176.
8. DeClue JE, Papageorge AG, Fletcher JA, Diehl SR, Ratner N, Vass WC, Lowry DR. 1992. Abnormal regulation of mammalian P21 ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265-273.
9. DeClue J, Heffelfinger S, Benvenuto G, Ling B, Li S, Rui W, Vass WC, Viskochil D, Ratner N. 2000. Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models. J Invest Dermatol 105:1233-1241.
10. Delaney CL, Cheng H-L, Feldman E. 1999. Insulin-like growth factor-I prevents caspase mediated apoptosis in Schwann cells. J Neurobiol 41: 540-548.
11. Ducatman BS, Scheithauer BW, Piepgrass DG, Reiman HM, Ilstrup DM. 1986. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006-2021.
12. Ecclescon PA, Funa K, Heldin C. 1993. Expression of platelet-derived growth factor (PDGF) and PDGF α and β receptors in the peripheral nervous system: an analysis of sciatic nerve and dorsal root ganglia. Dev Biol 155:450-470.
13. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E. Moran A. 2002. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. J Med Genet 39:311-314.
14. Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T, Boss G. 1996. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12:507-513.
15. Guo FF, Tong J, Hannan F, Luo L, Zhong Y. 2000. A neurofibromatosis 1 regulated pathway is required for learning in Drosophila. Nature 403: 895-898.
16. Jones SM, Kazlauskas A. 2000. Connecting signaling and cell cycle progression in growth factor-stimulated cells. Oncogene 19:5558-5567.
17. Kazlauskas A. 1994. Receptor tyrosine kinases and their targets. Curr Opin Genet Dev 4:5-14.
18. Kazlauskas A, Kashishian A, Cooper JA, Valius M. 1992. GTPase-activating protein and phophatidylinositol-3 kinase bind to distinct regions of the platelet-derived growth factor receptor β subunit. Mol Cell Biol 12: 2534-2544.
19. Kim HA, Rosenbaum T, Marchionni MA, Ratner N, DeClue JE. 1995. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes. Oncogene 11:325-335.
20. Kim HA, Ratner N, Roberts TM, Stiles CD. 2001. Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1. J Neurosci 21:1110-1116.
21. Li H, Velasco-Miguel S, Vass WC, Parada LF, DeClue JF. 2002. Epidermal growth factor receptor signaling pathways are associated with tumorigenesis in the Nf1:p53 mouse tumor model. Cancer Res 62:4507-4513.
22. Li Y, Rao PK, Wen R, Song Y, Muir D, Wallace P, van Home SJ, Tennekoon GI, Kadesch T. 2004. Notch and Schwann cell transformation. Oncogene 23:1146-1152.
23. Lyons SA, Morell P, McKarthy KD. 1995. Schwann cell ATP-mediated calcium increases in vitro and in situ are dependent on contact with neurons. Glia 13:27-38.
24. Maurel P, Salzer JL. 2000. Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity. J Neurosci 20:4635-4645.
25. Menon AG, Anderson KM, Ricardi VM, Chung RY, Whaley JM, Yandell DW, Farmer GE, Frieman RN, Lee JK, Li FP. 1990. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A 87:5435-5439.
26. Morioka N, Tsuchida T, Etoh T, Ishibashi Y, Otsuka F. 1990. A case of neurofibrosarcoma associated with neurofibromatosis: light microscopic, ultrastructural, immunohistochemical and biochemical investigations. J Dermatol 17:312-316.
27. North RA, Barnard EA. 1997. Nucleotide receptors. Curr Opin Neurobiol 7:346-357.
28. Oya T, Zhao Y-L, Takagawa K, Kawaguchi M, Shirakawa K, Yamauchi T, Sasahra M. 2002. Platelet-derived growth factor-B Expression induced after rat peripheral nerve injuries. Glia 38:303-312.
29. Perry A, Kunz SN, Fuller CE, Banerjee R, Marley EF, Liapis H, Watson MA, Gutmann DH. 2002. Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms. J Neuropathol Exp Neurol 61:702-709.
30. Rosenbaum T, Petrie KM, Ratner N. 1997. Neurofibromatosis type 1: genetic and cellular mechanisms of peripheral nerve tumor formation. Neuroscientist 3:412-420.
31. Sangueza OP, Requena L. 1998. Neoplasms with neural differentiation: a review. Part II. Malignant neoplasms. Am J Dermapathol 20:89-102.
32. Sherman LS, Atit R, Rosenbaum T, Cox A, Ratner N. 2000. Single cell Ras-GTP analysis reveals altered ras activity in a subpopulation of neurofibroma Schwann cells but not in fibroblasts. J Biol Chem 275:30740-30745.
33. Side LE, Emmanuel PD, Taylor B, Franklin J, Thompson P, Castleberry RP, Shannon KM. 1998. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 92:267-272.
34. Stevens B, Fields RD. 2000. Response of Schwann cells to action potentials in development. Science 287:2267-2271.
35. Su W, Sin M, Darrow A, Sherman L. 2003. Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression. Glia 42:350-358.
36. Tong J, Hannan F, Zhu Y, Bernards A, Zhong Y. 2002. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat Neurosci 5:95-96.
37. Vogel KS, Klesse LJ, Velasco-Miguel S, Meyers K, Rushing EJ, Parada LF. 1999. Mouse tumor model for neurofibromatosis type 1. Science 286: 2176-2179.
38. Watanabe T, Oda Y, Tamiya S, Masuda K, Tsuneyoshi M. 2001. Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components. J Clin Pathol 54:631-636.
39. Weinmaster G, Lemke G. 1990. Cell-specific cyclic AMP-mediated induction of PDGF receptor. EMBO J 9:915-920.
40. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. 1998. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Phys 42:351-360.
41. Yoder EJ, Tamir H, Ellisman MH. 1996. 5-Hydroxytryptamine 2A receptors on cultured rat Schwann cells. Glia 17:15-27.
42. Zhu Y, Ghosh P, Charnay P, Burns DK, Parada LF. 2002. Neurofibromatosis in NF1: Schwann Cell origin and role of tumor environment Science 296:920-922.